Article info

Original research
Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study

Authors

  1. Correspondence to Ms Ingrid Anne Lie, Department of Clinical Medicine, University of Bergen, Bergen, Norway; ingrid.lie{at}uib.no
View Full Text

Citation

Lie IA, Kaçar S, Wesnes K, et al
Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study

Publication history

  • Received December 3, 2021
  • Accepted May 18, 2022
  • First published June 1, 2022.
Online issue publication 
July 14, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.